Annual SGA
$85.49 M
+$10.31 M+13.72%
December 31, 2024
Summary
- As of March 13, 2025, ABCL annual SGA is $85.49 million, with the most recent change of +$10.31 million (+13.72%) on December 31, 2024.
- During the last 3 years, ABCL annual SGA has risen by +$36.73 million (+75.32%).
- ABCL annual SGA is now at all-time high.
Performance
ABCL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$19.16 M
-$3.12 M-13.99%
December 31, 2024
Summary
- As of March 13, 2025, ABCL quarterly SGA is $19.16 million, with the most recent change of -$3.12 million (-13.99%) on December 31, 2024.
- Over the past year, ABCL quarterly SGA has dropped by -$3.12 million (-13.99%).
- ABCL quarterly SGA is now -17.85% below its all-time high of $23.33 million, reached on June 30, 2024.
Performance
ABCL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$709.49 M
-$162.86 M-18.67%
December 31, 2024
Summary
- As of March 13, 2025, ABCL TTM SGA is $709.49 million, with the most recent change of -$162.86 million (-18.67%) on December 31, 2024.
- Over the past year, ABCL TTM SGA has increased by +$624.09 million (+730.78%).
- ABCL TTM SGA is now -59.41% below its all-time high of $1.75 billion.
Performance
ABCL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ABCL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.7% | -14.0% | +730.8% |
| 3 y3 years | +75.3% | -14.0% | +730.8% |
| 5 y5 years | +2030.9% | -14.0% | +730.8% |
ABCL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.3% | -17.9% | +30.2% | -59.4% | at low |
| 5 y | 5-year | at high | +2030.9% | -17.9% | +1225.2% | -59.4% | +9543.3% |
| alltime | all time | at high | +2886.0% | -17.9% | +1225.2% | -59.4% | +9543.3% |
AbCellera Biologics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $85.49 M(+13.7%) | $19.16 M(-14.0%) | $85.49 M(+0.1%) |
| Sep 2024 | - | $22.28 M(-4.5%) | $85.40 M(+5.5%) |
| Jun 2024 | - | $23.33 M(+12.6%) | $80.96 M(+5.2%) |
| Mar 2024 | - | $20.72 M(+8.6%) | $76.99 M(+2.4%) |
| Dec 2023 | $75.18 M(+12.6%) | $19.07 M(+6.9%) | $75.18 M(+4.7%) |
| Sep 2023 | - | $17.84 M(-7.9%) | $71.81 M(+1.3%) |
| Jun 2023 | - | $19.36 M(+2.4%) | $70.85 M(+2.7%) |
| Mar 2023 | - | $18.91 M(+20.4%) | $69.02 M(+3.4%) |
| Dec 2022 | $66.75 M | $15.71 M(-7.0%) | $66.76 M(+1.5%) |
| Sep 2022 | - | $16.88 M(-3.7%) | $65.77 M(+7.2%) |
| Jun 2022 | - | $17.53 M(+5.4%) | $61.38 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $16.64 M(+13.1%) | $56.34 M(+15.7%) |
| Dec 2021 | $48.76 M(+209.6%) | $14.72 M(+17.8%) | $48.70 M(+15.9%) |
| Sep 2021 | - | $12.49 M(-0.1%) | $42.01 M(+26.9%) |
| Jun 2021 | - | $12.50 M(+38.9%) | $33.12 M(+46.1%) |
| Mar 2021 | - | $9.00 M(+12.1%) | $22.66 M(+43.9%) |
| Dec 2020 | $15.75 M(+292.6%) | $8.03 M(+123.3%) | $15.75 M(+71.7%) |
| Sep 2020 | - | $3.59 M(+75.7%) | $9.17 M(+64.4%) |
| Jun 2020 | - | $2.04 M(-2.0%) | $5.58 M(+57.9%) |
| Mar 2020 | - | $2.09 M(+44.3%) | $3.53 M(+144.3%) |
| Dec 2019 | $4.01 M(+40.1%) | $1.45 M | $1.45 M |
| Dec 2018 | $2.86 M | - | - |
FAQ
- What is AbCellera Biologics annual SGA?
- What is the all time high annual SGA for AbCellera Biologics?
- What is AbCellera Biologics annual SGA year-on-year change?
- What is AbCellera Biologics quarterly SGA?
- What is the all time high quarterly SGA for AbCellera Biologics?
- What is AbCellera Biologics quarterly SGA year-on-year change?
- What is AbCellera Biologics TTM SGA?
- What is the all time high TTM SGA for AbCellera Biologics?
- What is AbCellera Biologics TTM SGA year-on-year change?
What is AbCellera Biologics annual SGA?
The current annual SGA of ABCL is $85.49 M
What is the all time high annual SGA for AbCellera Biologics?
AbCellera Biologics all-time high annual SGA is $85.49 M
What is AbCellera Biologics annual SGA year-on-year change?
Over the past year, ABCL annual SGA has changed by +$10.31 M (+13.72%)
What is AbCellera Biologics quarterly SGA?
The current quarterly SGA of ABCL is $19.16 M
What is the all time high quarterly SGA for AbCellera Biologics?
AbCellera Biologics all-time high quarterly SGA is $23.33 M
What is AbCellera Biologics quarterly SGA year-on-year change?
Over the past year, ABCL quarterly SGA has changed by -$3.12 M (-13.99%)
What is AbCellera Biologics TTM SGA?
The current TTM SGA of ABCL is $709.49 M
What is the all time high TTM SGA for AbCellera Biologics?
AbCellera Biologics all-time high TTM SGA is $1.75 B
What is AbCellera Biologics TTM SGA year-on-year change?
Over the past year, ABCL TTM SGA has changed by +$624.09 M (+730.78%)